Interleukin-15 and -21-activated, donor-derived NK cell infusion after haploidentical HCT in high-risk AML and MDS-a
Kyoo-Hyung Lee1, Sewon Lee2, Young Hoon Park2
1Ewha Womans University Medical Center, Mokdong Hospital, Seoul, Republic of Korea. haploset@gmail.com.
Leukemia
|December 22, 2023
Abstract
No abstract available in PubMed .


